Core Insights - Ecolab reported $4.03 billion in revenue for Q2 2025, a 1% year-over-year increase, with an EPS of $1.89 compared to $1.68 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $4.01 billion by 0.42%, while the EPS fell short of the consensus estimate of $1.90 by 0.53% [1] Financial Performance Metrics - Global Pest Elimination sales were $311.3 million, slightly above the estimated $309.06 million [4] - Global Water sales were $1.91 billion, below the estimated $1.92 billion, reflecting a 2.4% decrease year-over-year [4] - Global Life Sciences sales were $176.7 million, below the estimated $179.14 million [4] - Global Institutional & Specialty sales reached $1.51 billion, slightly below the estimated $1.53 billion, but showed a 10.1% year-over-year increase [4] - Operating Income for Global Life Sciences was $34.8 million, exceeding the estimate of $27.2 million [4] - Operating Income for Global Pest Elimination was $61.2 million, slightly above the estimated $60.41 million [4] - Corporate Operating Income was reported at -$75 million, worse than the estimated -$48.9 million [4] Stock Performance - Ecolab's shares returned +0.2% over the past month, underperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]